Walgreens Debt to Equity Ratio 2010-2024 | WBA

Current and historical debt to equity ratio values for Walgreens (WBA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Walgreens debt/equity for the three months ending August 31, 2024 was 0.67.
Walgreens Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-08-31 $69.03B $12.01B 5.75
2024-05-31 $67.73B $15.26B 4.44
2024-02-29 $69.02B $15.19B 4.54
2023-11-30 $70.24B $27.59B 2.55
2023-08-31 $68.31B $28.32B 2.41
2023-05-31 $69.25B $29.36B 2.36
2023-02-28 $71.04B $29.44B 2.41
2022-11-30 $68.29B $24.58B 2.78
2022-08-31 $60.76B $29.37B 2.07
2022-05-31 $62.38B $30.38B 2.05
2022-02-28 $61.82B $30.87B 2.00
2021-11-30 $65.93B $30.58B 2.16
2021-08-31 $57.46B $23.82B 2.41
2021-05-31 $69.32B $22.60B 3.07
2021-02-28 $69.30B $21.63B 3.20
2020-11-30 $68.60B $20.56B 3.34
2020-08-31 $66.04B $21.14B 3.12
2020-05-31 $65.12B $21.32B 3.05
2020-02-29 $65.67B $24.33B 2.70
2019-11-30 $66.50B $24.31B 2.74
2019-08-31 $43.45B $24.15B 1.80
2019-05-31 $43.82B $24.77B 1.77
2019-02-28 $45.02B $25.41B 1.77
2018-11-30 $43.68B $26.26B 1.66
2018-08-31 $41.44B $26.69B 1.55
2018-05-31 $41.68B $28.47B 1.46
2018-02-28 $42.64B $28.18B 1.51
2017-11-30 $39.86B $26.76B 1.49
2017-08-31 $37.74B $28.27B 1.34
2017-05-31 $42.69B $31.48B 1.36
2017-02-28 $42.08B $30.42B 1.38
2016-11-30 $42.22B $29.69B 1.42
2016-08-31 $42.41B $30.28B 1.40
2016-05-31 $36.02B $31.31B 1.15
2016-02-29 $36.47B $29.92B 1.22
2015-11-30 $37.50B $31.15B 1.20
2015-08-31 $37.48B $31.30B 1.20
2015-05-31 $38.72B $31.93B 1.21
2015-02-28 $40.33B $31.03B 1.30
2014-11-30 $27.85B $20.77B 1.34
2014-08-31 $16.63B $20.62B 0.81
2014-05-31 $15.91B $21.49B 0.74
2014-02-28 $16.25B $20.83B 0.78
2013-11-30 $16.43B $20.06B 0.82
2013-08-31 $16.03B $19.45B 0.82
2013-05-31 $16.86B $18.98B 0.89
2013-02-28 $16.59B $18.97B 0.87
2012-11-30 $16.88B $18.38B 0.92
2012-08-31 $15.23B $18.24B 0.84
2012-05-31 $12.16B $15.04B 0.81
2012-02-29 $11.81B $14.82B 0.80
2011-11-30 $12.76B $14.67B 0.87
2011-08-31 $12.61B $14.85B 0.85
2011-05-31 $12.59B $14.72B 0.86
2011-02-28 $12.20B $14.68B 0.83
2010-11-30 $12.68B $14.36B 0.88
2010-08-31 $11.88B $14.40B 0.83
2010-05-31 $11.60B $15.11B 0.77
2010-02-28 $11.39B $14.95B 0.76
2009-11-30 $11.93B $14.62B 0.82
2009-08-31 $10.77B $14.38B 0.75
2009-05-31 $10.96B $14.19B 0.77
2009-02-28 $11.15B $13.68B 0.82
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $8.179B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $70.208B 7.47
Herbalife (HLF) Cayman Islands $0.789B 4.16
China Jo-Jo Drugstores Holdings (CJJD) China $0.016B 0.00
GNC Holdings (GNC) United States $0.000B 0.00